One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
      • Luxury & premium products
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Healthcare IT
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
    • Automotive and Transportation
      • Automotive components
      • Automotive Logistics
      • Automotive systems and accessories
    • Information and Communications Technology
      • E Commerce and Outsourcing
      • Entertainment & Media
      • High Tech | Enterprise & Consumer IT
      • Information & Network Security
      • Mobility | Telecom & Wireless
      • Software and Services
    • Semiconductor and Electronics
      • Semiconductor Materials and Components
      • Display Technology
      • Electronics System and Components
      • Emerging technologies
      • Security and Surveillance
      • Sensors and Controls
    • Building and Construction
      • Construction Materials
      • HVAC
      • Residential Construction and Improvement
      • Roads & Highways
    • Manufacturing
      • Manufacturing Services
      • Heavy Manufacturing
      • Packaging
      • Engineering | Equipment and Machinery
  • Who Trust Us
  • [email protected]
  • +1 718 874 1545 (International)
  • +91 78878 22626 (Asia)

More Results

One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
      • Luxury & premium products
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Healthcare IT
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
    • Automotive and Transportation
      • Automotive components
      • Automotive Logistics
      • Automotive systems and accessories
    • Information and Communications Technology
      • E Commerce and Outsourcing
      • Entertainment & Media
      • High Tech | Enterprise & Consumer IT
      • Information & Network Security
      • Mobility | Telecom & Wireless
      • Software and Services
    • Semiconductor and Electronics
      • Semiconductor Materials and Components
      • Display Technology
      • Electronics System and Components
      • Emerging technologies
      • Security and Surveillance
      • Sensors and Controls
    • Building and Construction
      • Construction Materials
      • HVAC
      • Residential Construction and Improvement
      • Roads & Highways
    • Manufacturing
      • Manufacturing Services
      • Heavy Manufacturing
      • Packaging
      • Engineering | Equipment and Machinery
  • Who Trust Us
Home ➤ Life Science ➤ Pharmaceuticals ➤ Androgenetic Alopecia Market
Androgenetic Alopecia Market
Androgenetic Alopecia Market
Published date: April 2025 • Formats:
Request Sample Schedule a Call
  • Home ➤ Life Science ➤ Pharmaceuticals ➤ Androgenetic Alopecia Market

Global Androgenetic Alopecia Market By Gender (Male and Female), By Treatment (Pharmaceuticals and Devices), By End-use (Dermatology Clinics and Homecare Settings), By Sales Channel (Prescriptions and OTC), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

  • Published date: April 2025
  • Report ID: 146218
  • Number of Pages: 215
  • Format:
  • Overview
  • Table of Contents
  • Major Market Players
  • Request a Free Sample
  • Quick Navigation

    • Report Overview
    • Key Takeaways
    • Gender Analysis
    • Treatment Analysis
    • End-Use Analysis
    • Sales Channel Analysis
    • Key Market Segments
    • Drivers
    • Restraints
    • Opportunities
    • Impact of Macroeconomic / Geopolitical Factors
    • Latest Trends
    • Regional Analysis
    • Key Players Analysis
    • Recent Developments
    • Report Scope

    Report Overview

    Global Androgenetic Alopecia Market size is expected to be worth around US$ 6.7 billion by 2034 from US$ 3.0 billion in 2024, growing at a CAGR of 8.4% during the forecast period 2025 to 2034. In 2024, North America led the market, achieving over 38.4% share with a revenue of US$ 1.2 Billion.

    Increasing awareness about hair loss treatments and the growing desire for aesthetic improvement are driving the rapid expansion of the androgenetic alopecia market. This market encompasses a variety of treatment options, including topical solutions, oral medications, hair transplants, and innovative therapies aimed at regrowing hair and preventing further loss.

    Rising incidences of androgenetic alopecia, combined with the increasing willingness of individuals to seek aesthetic solutions, further contribute to market growth. Recent advances in pharmaceutical formulations, such as finasteride and minoxidil, have proven effective in addressing hair loss, with further research focusing on stem cell and regenerative treatments.

    Androgenetic Alopecia Market Size

    In June 2023, Dr. Reddy’s Laboratories Ltd. launched RgenX, a dedicated division within its generics business in India, aimed at providing a broader range of affordable medicines. This initiative reflects the growing demand for accessible and cost-effective treatments for various conditions, including androgenetic alopecia. As the market for hair loss treatments continues to evolve, opportunities for innovative and personalized solutions expand, driving growth and competition in the sector.

    Key Takeaways

    • In 2023, the market for Androgenetic Alopecia generated a revenue of US$ 3.0 billion, with a CAGR of 8.4%, and is expected to reach US$ 6.7 billion by the year 2033.
    • The gender segment is divided into male and female, with male taking the lead in 2023 with a market share of 61.5%.
    • Considering treatment, the market is divided into pharmaceuticals and devices. Among these, pharmaceuticals held a significant share of 58.3%.
    • Furthermore, concerning the end-use segment, the market is segregated into dermatology clinics and homecare settings. The dermatology clinics sector stands out as the dominant player’s holding the largest revenue share of 62.0% in the Androgenetic Alopecia market.
    • The sales channel segment is segregated into prescriptions and OTC, with the prescriptions segment leading the market, holding a revenue share of 55.2%.
    • North America led the market by securing a market share of 38.4% in 2023

    Gender Analysis

    The male segment led in 2023, claiming a market share of 61.5% owing to the increasing prevalence of hair loss among men. Factors such as rising stress levels, poor lifestyle habits, and genetics contribute to the growing demand for effective treatments targeting male pattern baldness.

    As awareness of available treatments increases and more men seek solutions to combat hair loss, the market for male-targeted hair loss treatments is anticipated to expand. Additionally, the growing trend of self-care and the increasing number of grooming and wellness products designed for men are likely to fuel the growth of this segment in the coming years.

    Treatment Analysis

    The pharmaceuticals held a significant share of 58.3% due to the continuous advancements in pharmaceutical treatments for hair loss. Oral medications, such as finasteride and dutasteride, have gained popularity for their effectiveness in treating androgenetic alopecia by inhibiting the hormone dihydrotestosterone (DHT), which is responsible for hair thinning.

    As research progresses and new pharmaceutical options are introduced, the demand for oral treatments is expected to increase. Furthermore, the convenience and efficacy of pharmaceutical solutions over topical treatments are anticipated to contribute to the segment’s expansion.

    End-Use Analysis

    The dermatology clinics segment had a tremendous growth rate, with a revenue share of 62.0% as more individuals seek professional treatments for hair loss. Dermatologists offer specialized services, including hair transplants, platelet-rich plasma (PRP) therapy, and laser treatments, which are becoming increasingly popular due to their effectiveness.

    The rising number of dermatology clinics specializing in hair restoration treatments and the growing number of patients seeking medical-grade solutions are expected to drive growth in this segment. Additionally, as awareness of advanced treatments continues to spread, more individuals are likely to visit clinics for personalized care.

    Sales Channel Analysis

    The prescriptions segment grew at a substantial rate, generating a revenue portion of 55.2% as prescribed treatments for hair loss gain more recognition for their effectiveness. Prescription treatments, such as finasteride and topical minoxidil, have long been proven to help reduce hair loss and promote hair regrowth.

    As healthcare professionals recommend these treatments more frequently, the prescriptions segment is expected to experience significant growth. The increasing number of individuals seeking professional consultations and prescriptions for hair loss is likely to further fuel the demand for prescription-based solutions, contributing to the market’s expansion.

    Androgenetic Alopecia Market Share

    Key Market Segments

    By Gender

    • Male
    • Female

    By Treatment

    • Pharmaceuticals
    • Devices

    By End-use

    • Dermatology Clinics
    • Homecare Settings

    By Sales Channel

    • Prescriptions
    • OTC

    Drivers

    Increasing Prevalence of Hair Loss Disorders is Driving the Market

    The rising incidence of androgenetic alopecia, particularly among younger populations, is a major market driver. Studies indicate that 50% of men and 25% of women experience noticeable hair loss by age 50, according to the American Academy of Dermatology (2023). The National Institutes of Health (NIH) reported a 15% increase in hair loss consultations from 2022 to 2023, reflecting growing awareness.

    Pharmaceutical companies like Pfizer (HairMax) and Johnson & Johnson (Rogaine) have seen 7-9% revenue growth in their hair loss treatment divisions in 2023. Social media and celebrity endorsements are further normalizing treatments, accelerating adoption. Emerging markets in Asia and Latin America are also contributing to growth due to increasing disposable incomes and medical tourism for hair restoration.

    Restraints

    High Treatment Costs and Side Effects are Restraining the Market

    The expense and potential adverse effects of hair loss therapies limit widespread adoption. The average annual cost of FDA-approved treatments like finasteride and minoxidil ranges from US$500 to US$1,200, making them unaffordable for many. Additionally, 10-15% of users report side effects such as sexual dysfunction or scalp irritation.

    Surgical options like hair transplants can cost US$4,000 to US$15,000 per procedure, further restricting accessibility. Insurance coverage for these treatments remains limited, with only 5% of US health plans offering reimbursement. These factors discourage long-term adherence, particularly in low- and middle-income regions, hindering market expansion.

    Opportunities

    Advancements in Stem Cell and Gene Therapy are Creating Growth Opportunities

    Breakthroughs in regenerative medicine and personalized treatments present significant opportunities for the market. Companies like Stemson Therapeutics and HairClone are pioneering stem cell-based hair regeneration, with clinical trials showing 30-40% follicle reactivation rates. Gene-editing technologies like CRISPR are also being explored, with NIH grants funding research on genetic predictors of hair loss.

    These innovations could revolutionize treatment efficacy and reduce reliance on lifelong medications, unlocking premium pricing potential. Emerging biotech startups are partnering with dermatology clinics to accelerate commercialization, particularly in the US and Europe.

    Impact of Macroeconomic / Geopolitical Factors

    Economic stability and healthcare spending directly influence the hair loss treatment market, with North America and Europe dominating due to high disposable incomes and insurance coverage. Inflation, however, has raised production costs, with price hikes for topical treatments. Geopolitical tensions, like US-China trade disputes, disrupted supply chains for raw materials like minoxidil, delaying manufacturing.

    Conversely, medical tourism in Turkey and India is thriving, offering affordable hair transplants and boosting local economies. Governments in Japan and South Korea are subsidizing regenerative medicine research, fostering innovation.

    Telehealth expansions post-pandemic have also improved access to prescriptions, with significant growth in online dermatology consultations. Despite short-term challenges, the convergence of biotech advancements and consumer demand for holistic solutions ensures robust long-term growth.

    Latest Trends

    Rising Demand for Non-Invasive and Natural Solutions is a Recent Trend

    Consumers are increasingly opting for minimally invasive and plant-based hair loss treatments, reshaping the market. At-home devices like laser caps and microneedling rollers saw a notable sales surge, with Capillus and iRestore leading the segment.

    Social media influencers and telehealth platforms are amplifying this shift, with a significant percentage of dermatologists noting increased patient inquiries about natural alternatives. Pharmaceutical companies are responding by integrating botanicals like saw palmetto and caffeine into their formulations, blending science with wellness trends.

    Regional Analysis

    North America is leading the Androgenetic Alopecia Market

    North America dominated the market with the highest revenue share of 38.4% owing to rising prevalence, increased treatment adoption, and advancements in therapeutic options. According to the National Institutes of Health (NIH), approximately 50 million men and 30 million women in the US were affected by pattern hair loss in 2023, up from 48 million and 28 million respectively in 2022.

    The US Food and Drug Administration (FDA) approved two new topical formulations for hair regrowth in early 2024, expanding treatment accessibility. Pharmaceutical companies like Pfizer and Eli Lilly reported an increase in sales of finasteride and minoxidil products in 2023, as disclosed in their annual financial statements. The American Academy of Dermatology (AAD) noted a rise in patient consultations for hair loss treatments between 2022 and 2023, reflecting growing awareness.

    Additionally, the Canadian Dermatology Association reported a surge in demand for platelet-rich plasma (PRP) therapies for hair restoration in 2023. Insurance coverage expansions for FDA-approved treatments, highlighted by the Centers for Medicare & Medicaid Services (CMS) in late 2023, further accelerated market growth.

    The Asia Pacific region is expected to experience the highest CAGR during the forecast period

    Asia Pacific is expected to grow with the fastest CAGR owing to increasing disposable income, rising aesthetic consciousness, and improving healthcare infrastructure. The Indian Journal of Dermatology reported an increase in clinical visits for hair loss in 2023 compared to 2022, driven by greater awareness. China’s National Health Commission (NHC) approved three new topical treatments in early 2024, likely boosting adoption rates.

    Japan’s Ministry of Health, Labour and Welfare (MHLW) recorded a rise in prescriptions for 5-alpha reductase inhibitors since 2022, reflecting growing treatment demand. South Korea’s Dermatological Society noted a surge in hair transplant procedures between 2022 and 2023, indicating strong market potential.

    The Australian Therapeutic Goods Administration (TGA) fast-tracked approvals for two novel therapies in 2023, expected to drive future growth. Governments across Southeast Asia are anticipated to invest more in dermatological care, with Thailand’s Ministry of Public Health allocating US$10 million for hair loss research in 2024. Key players like Merck and Johnson & Johnson are likely to expand their regional presence, further stimulating market expansion.

    Androgenetic Alopecia Market Region

    Key Regions and Countries

    North America

    • US
    • Canada

    Europe

    • Germany
    • France
    • The UK
    • Spain
    • Italy
    • Russia
    • Netherland
    • Rest of Europe

    Asia Pacific

    • China
    • Japan
    • South Korea
    • India
    • Australia
    • New Zealand
    • Singapore
    • Thailand
    • Vietnam
    • Rest of APAC

    Latin America

    • Brazil
    • Mexico
    • Rest of Latin America

    Middle East & Africa

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA

    Key Players Analysis

    Key players in the androgenetic alopecia market focus on product innovation, expanding their treatment options, and increasing market accessibility to drive growth. They invest in developing new therapies, such as topical treatments, oral medications, and hair restoration devices, to address varying patient needs. Companies also collaborate with healthcare providers, dermatologists, and research institutions to enhance product development and improve clinical outcomes.

    Strategic partnerships and digital marketing help these companies reach wider audiences, particularly in emerging markets where awareness of hair loss treatments is growing. Additionally, improving patient access to treatments through cost-effective solutions helps boost adoption rates.

    Johnson & Johnson, headquartered in New Brunswick, New Jersey, is a global leader in healthcare and pharmaceutical products. The company offers minoxidil, marketed under the Rogaine brand, as one of the most well-known treatments for hair loss. Johnson & Johnson focuses on research and development, continuously working to improve the effectiveness of its products. With a broad global presence and a strong focus on dermatology, the company remains a significant player in the hair loss treatment market, aiming to provide innovative solutions to meet patient needs worldwide.

    Top Key Players

    • Sun Pharmaceutical Industries Ltd
    • Merck & Co., Inc
    • Lexington Intl., LLC
    • Reddy’s Laboratories Ltd
    • Curallux, LLC
    • Cosmo Pharmaceuticals
    • Aurobindo Pharma
    • Apira Science, Inc

    Recent Developments

    • In December 2023, Sun Pharmaceutical Industries Ltd. formed a strategic partnership with Aclaris to gain exclusive rights to the use of deuruxolitinib JAK inhibitor, or other isotopic forms of ruxolitinib. This collaboration focuses on developing treatments for alopecia areata and androgenetic alopecia, expanding Sun Pharma’s portfolio in dermatology.
    • In July 2023, Cosmo Pharmaceuticals began phase 3 clinical trials for Clascoterone Solution, a topical androgen receptor-blocking drug aimed at treating hair loss conditions. This marks a significant step in the company’s efforts to introduce new treatment options for dermatological disorders.

    Report Scope

    Report Features Description
    Market Value (2024) US$ 3.0 Billion
    Forecast Revenue (2034) US$ 6.7 Billion
    CAGR (2025-2034) 8.4%
    Base Year for Estimation 2024
    Historic Period 2020-2023
    Forecast Period 2025-2034
    Report Coverage Revenue Forecast, Market Dynamics, COVID-19 Impact, Competitive Landscape, Recent Developments
    Segments Covered By Gender (Male and Female), By Treatment (Pharmaceuticals and Devices), By End-use (Dermatology Clinics and Homecare Settings), By Sales Channel (Prescriptions and OTC)
    Regional Analysis North America – US, Canada; Europe – Germany, France, The UK, Spain, Italy, Russia, Netherlands, Rest of Europe; Asia Pacific – China, Japan, South Korea, India, Australia, New Zealand, Singapore, Thailand, Vietnam, Rest of APAC; Latin America – Brazil, Mexico, Rest of Latin America; Middle East & Africa – South Africa, Saudi Arabia, UAE, Rest of MEA
    Competitive Landscape Sun Pharmaceutical Industries Ltd, Merck & Co., Inc, Lexington Intl., LLC, Dr. Reddy’s Laboratories Ltd, Curallux, LLC, Cosmo Pharmaceuticals, Aurobindo Pharma, and Apira Science, Inc.
    Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements.
    Purchase Options We have three licenses to opt for: Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF)

     

    Androgenetic Alopecia Market
    Androgenetic Alopecia Market
    Published date: April 2025
    add_shopping_cartBuy Now get_appDownload Sample
    keyboard_arrow_up
    • Sun Pharmaceutical Industries Ltd
    • Merck & Co., Inc
    • Lexington Intl., LLC
    • Dr. Reddys Laboratories Ltd Company Profile
    • Curallux, LLC
    • Cosmo Pharmaceuticals
    • Aurobindo Pharma
    • Apira Science, Inc
  • settingsSettings

Related Reports

  • Smart Bandages Market
  • Corticosteroids Market
  • Antiseptic and Disinfectants Market
  • Over The Counter Analgesics Market
  • Antidepressant Drugs Market
  • Inhalable Drugs Market
  • Epilepsy Drug Market
  • High Potency Active Pharmaceutical Ingredients Market
  • Antidiabetics Market
  • Amniotic Products Market

Our Clients

  • Our Clients
Inquiry Before Buying

Androgenetic Alopecia Market
  • 146218
  • April 2025
    • ★★★★★
      ★★★★★
    • (142)
add_shopping_cart Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$6,000
$3,999
USD / per unit
save 24%
Multi User
$8,000
$5,999
USD / per unit
save 28%
Corporate User
$10,000
$6,999
USD / per unit
save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 3,999) Buy Now ($ 5,999) Buy Now ($ 6,999)
  • location_on420 Lexington Avenue, Suite 300 New York City, NY 10170,
    United States
  • phone+1 718 874 1545 (International)
  • phone+91 78878 22626 (Asia)
  • email[email protected]
  • Facebook Logo
  • Twitter Logo
  • LinkedIn Logo
Find Help
  • Contact Us
  • How to Order
Legal
  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions
Explore
  • About Us
  • All Reports
  • All Sectors
  • Infographics
  • Statistics and Facts
  • Companies
Secured Payment Options
Secured Payment Options

© 2025 Market.Us. All Rights Reserved.